Carregant...
Challenges to Demonstrating Disease-Modifying Effects in Alzheimer’s Disease Clinical Trials
Progress in understanding the molecular biology of Alzheimer’s disease (AD) has provided a number of plausible therapeutic targets for disease-modifying interventions. To advance these agents towards eventual Food and Drug Administration (FDA) approval and incorporation into clinical practice by phy...
Guardat en:
| Publicat a: | Alzheimers Dement |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854177/ https://ncbi.nlm.nih.gov/pubmed/19595897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2006.07.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|